COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC:
Get the latest research information from NIH:

Coronavirus Guidance for NIH Applicants and Grantees:


Division of Translational and Clinical Sciences DTCS
Oncology 2 – Translational Clinical OTC

After earning a Ph.D. (1987) in bioorganic chemistry from George Washington University, Dr. Quadri has conducted basic and translational research focused on human cancers. He began his academic career at the Johns Hopkins Oncology Center, where he was an assistant professor in the Radiation Oncology Department and studied radionuclide targeted therapy. Dr. Quadri has held other faculty positions at prestigious academic institutions and oncology centers in the United States before joining CSR in 1996 as an SRO.